Fig. 3

Serum DNA methylation analysis in women with benign and malignant conditions of the female genital tract. Pattern frequencies for the different regions and CA125 levels analyzed in serum set 3 samples are shown and horizontal red bars denote the mean (a–d; ns not significant; *p < 0.05, **p < 0.01, ***p < 0.001; Mann–Whitney U test compared to HGS; H healthy, BPM benign pelvic mass, BOT borderline tumors, NET non-epithelial tumors, OCM other cancerous malignancies, NHGS non-high grade serous ovarian cancers, HGS high grade serous, OC ovarian cancers)